The impact of blood glucose on community-acquired pneumonia: a retrospective cohort study Source: ERJ Open Res, 3 (2) 00114-2016; 10.1183/23120541.00114-2016 Year: 2017
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Do not resuscitat orders in community-acquired pneumonia: a restrospective cohort study. Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006
Association between biomarkers at discharge and risk of readmission after community-acquired pneumonia – a retrospective cohort study Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Undiagnosed diabetes mellitus in community-acquired pneumonia - A prospective cohort study Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008
Management of community-acquired pneumonia in primary care: an observational study Source: International Congress 2019 – Treatment of airway diseases in primary care Year: 2019
Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
The presence of diabetes mellitus does not influence clinical outcomes in patient with community-acquired pneumonia: Results from the CAPO international cohort study Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020 Year: 2020
Etiology of community-acquired pneumonia requiring hospitalization in Chile: a prospective study Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005
Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2003; 21: 294-302 Year: 2003
New evidence of risk factors for community-acquired pneumonia: a population-based study Source: Eur Respir J 2008; 31: 1274-1284 Year: 2008
Impact of bacteremia in a cohort of predominantly elderly patients with pneumococcal pneumonia. Epidemiologic and case-control study Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
The glycemic gap and 90-day mortality in community-acquired pneumonia- A prospective cohort study Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017